Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Inc. Completes $10 Million Bought Deal Financing

Marketwired February 18, 2016

Spectral Medical Inc. Announces $10,010,000 Bought Deal Financing

Marketwired January 28, 2016

Spectral Medical Provides Clinical and Regulatory Update

Marketwired January 11, 2016

CORRECTION: Spectral Announces Third Quarter 2015 Results

Marketwired November 13, 2015

Spectral Announces Third Quarter 2015 Results

Marketwired November 13, 2015

Spectral Files Third Module of Rolling PMA Submission to FDA

Marketwired November 12, 2015

Spectral Announces European Distribution Agreement With Fresenius Medical Care for Its Endotoxin Activity Assay (EAA(TM)) Diagnostic

Marketwired November 10, 2015

Spectral Announces European Distribution Agreement With Fresenius Medical Care for Its Endotoxin Activity Assay (EAA(TM)) Diagnostic

Marketwired November 10, 2015

Spectral Announces Presentations By Key Opinion Leaders at the Critical Care Canada Forum

Marketwired October 26, 2015

Spectral and Toray Medical Sign Exclusive EAA(TM) Distribution Agreement for 15 Countries in the Middle and Far East

Marketwired October 21, 2015

Body of Evidence Supporting the Use of Toraymyxin(TM) for Treatment of Septic Shock Continues to Grow

Marketwired October 19, 2015

IIROC Trade Resumption - Spectral Medical Inc.

Newsfile September 14, 2015

Spectral Now Recruiting the Last 75 Patients in Its Phase III Trial

Marketwired September 14, 2015

IIROC Trade Halt - Spectral Medical Inc.

Newsfile September 14, 2015

Spectral Announces Second Quarter 2015 Results

Marketwired August 14, 2015

Tech Roundup: (V.PTK) ‘POET ‘-RY in motion?, UrtheCast (T.UR) files Q2, Spectral (T.EDT) active

Gaalen Engen August 12, 2015

Spectral Announces Voting Results of Annual and Special Meeting

Marketwired May 13, 2015

Spectral Announces First Quarter 2015 Results

Marketwired May 13, 2015

Spectral Medical Provides Regulatory Update

Marketwired April 22, 2015

Spectral Ranks Amongst Top 10 Game-Changing Health Technologies

Marketwired April 16, 2015